|
ZNF134 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43160000520837E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.53949972162104E-10 |
| Normal-vs-Stage2 |
4.96070000000071E-06 |
| Normal-vs-Stage3 |
4.5528999459421E-09 |
| Normal-vs-Stage4 |
5.37529998290154E-09 |
| Stage1-vs-Stage2 |
8.000200E-01 |
| Stage1-vs-Stage3 |
1.116950E-01 |
| Stage1-vs-Stage4 |
8.614300E-02 |
| Stage2-vs-Stage3 |
4.036600E-01 |
| Stage2-vs-Stage4 |
2.561400E-01 |
| Stage3-vs-Stage4 |
6.242400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.63270000244731E-08 |
| Normal-vs-AfricanAmerican |
1.048360E-02 |
| Normal-vs-Asian |
6.47599999958892E-07 |
| Caucasian-vs-AfricanAmerican |
1.281170E-01 |
| Caucasian-vs-Asian |
9.394200E-01 |
| AfricanAmerican-vs-Asian |
1.757640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.2074000022011E-08 |
| Normal-vs-Female |
1.03479447233212E-11 |
| Male-vs-Female |
4.077800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.27709995304082E-09 |
| Normal-vs-Age(41-60Yrs) |
1.98990046662573E-10 |
| Normal-vs-Age(61-80Yrs) |
3.57740004286455E-09 |
| Normal-vs-Age(81-100Yrs) |
1.790380E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.017200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.134000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.331000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.482200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.354800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.077200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.200430E-02 |
| Classical-VS-Follicular |
2.920300E-03 |
| Classical-VS-Other |
1.976390E-01 |
| Classical-VS-Normal |
9.84950000004758E-07 |
| Tall-VS-Follicular |
9.855400E-01 |
| Tall-VS-Other |
7.580200E-01 |
| Tall-VS-Normal |
1.37690000512336E-08 |
| Follicular-VS-Other |
8.039800E-01 |
| Follicular-VS-Normal |
3.37500027924875E-10 |
| Other-VS-Normal |
3.616700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.65779628808127E-11 |
| Normal-vs-N1 |
4.95209995232671E-09 |
| N0-vs-N1 |
1.477360E-01 |
|
|
